Details

Analiza družbene odgovornosti podjetja BTC : diplomsko delo
ID Žehelj, Matic (Author), ID Hočevar, Marko (Mentor) More about this mentor... This link opens in a new window

URLURL - Presentation file, Visit http://www.cek.ef.uni-lj.si/UPES/zehelj876.pdf This link opens in a new window

Language:Slovenian
Keywords:Slovenija, trgovinsko podjetje, BTC, družbena odgovornost, varstvo okolja, voda, energija, odpadni material, promet, planiranje, kontrola
Work type:Bachelor thesis/paper
Typology:2.11 - Undergraduate Thesis
Organization:EF - School of Economics and Business
Place of publishing:Ljubljana
Publisher:[M. Žehelj]
Year:2011
Number of pages:II, 30, 10 str.
PID:20.500.12556/RUL-40966 This link opens in a new window
UDC:658
COBISS.SI-ID:20021222 This link opens in a new window
Publication date in RUL:10.07.2015
Views:2544
Downloads:250
Metadata:XML DC-XML DC-RDF
:
ŽEHELJ, Matic, 2011, Analiza družbene odgovornosti podjetja BTC : diplomsko delo [online]. Bachelor’s thesis. Ljubljana : M. Žehelj. [Accessed 26 March 2025]. Retrieved from: http://www.cek.ef.uni-lj.si/UPES/zehelj876.pdf
Copy citation
Share:Bookmark and Share

Secondary language

Language:Unknown
Keywords:Slovenia, commercial enterprise, social responsibility, environmental protection, water, energy, waste material, traffic, planning, control

Similar documents

Similar works from RUL:
  1. Systematic review and meta-analysis of observational studies evaluating treatment outcomes in patients with metastatic non-small-cell lung cancer on first-line immune checkpoint inhibitors therapy
  2. Description of adverse event of immune checkpoint inhibitors in patients with advanced non-small cell lung cancer treated at the University Clinic Golnik
  3. Effectivness and safety of immunotherapy in patients with advanced non-small cell lung cancer in second line treatment at the University Clinic Golnik
  4. Evaluation of possible pembrolizumab dosing regimen racionalisation in advanced non-small cell lung cancer
  5. ǂThe ǂpotential of immunotherapies in the treatment of lung cancer
Similar works from other Slovenian collections:
  1. ǂThe ǂrole of immune checkpoint inhibitors in the treatment of cancer of unknown origin
  2. Trans-esophageal endobronchial ultrasound-guided needle aspiration (EUS-B-NA)
  3. Febrile neutropenia and grade 3/4 neutropenia in daily practice of adjuvant chemotherapy for non-small-cell lung cancer
  4. Advances in the therapy with immune-check point inhibitors (ICI) in non-small cell lung cancer (NSCLC) in 2022
  5. Long-term survival of locally advanced stage III non-small cell lung cancer patients treated with chemoradiotherapy and perspectives for the treatment with immunotherapy

Back